A80 (1A)
Gender: Male and Female
Smoking habit: Smoker or non-smoker
Pot smoking
40 - 80
BMI : 18.5 - 41.9
Food restrictions : Fast
Clinic stay
- 17 Oct (17:30) to 23 Oct (09:00)
Participants must be available to stay at our clinic for all of the dates listed above and/or in the notes below. All clinic stays and return visits are mandatory. Times are subject to change.
Medication type
This drug is being developed for the potential treatment of chronic hepatitis C and coronavirus disease 2019 (COVID-19), a respiratory disease caused by a specific type of virus.
Notes
We are looking for participants with a mild renal function.
Phase 1 study.
12 hours fasting before medical exam. Don’t forget it’s important to drink lots of water prior to your medical exam. Fasting doesn’t mean you shouldn’t keep hydrated!
You will receive $100 after completing the medical exam.
Participants must be fasted prior to dosing.
Participants will remain seated for at least four hours after taking the medication.
Blood volume: Male 200ml / Female 200ml (19 blood draws). One overnight blood draw.
A follow-up telephone call will be made to all participants approximately seven days following the last drug administration.
Your medical history and/or medication intake history may affect your participation on this study.
Please note that we are testing for drugs and alcohol during the medical evaluation.
This is preliminary information and changes could occur without notice